Mekophar records first loss as major pharma firms post Q2 profits
Ho Chi Minh City-based Mekophar posted its first loss in the second quarter, while most other pharma industry majors in Vietnam reported significant profit growth.
Mekophar (MKP) reported a loss of VND104.5 billion ($4.4 million) in Q2, the first loss in its history. It earned net revenues of VND207 billion ($8.7 million), up 10% year-on-year, according to its financial statement.
The company attributed the loss to a decrease in market demand, impacts of competition from other businesses, and problems with registration numbers.
In the first six months of 2023, Mekophar posted net revenues and after-tax profits of VND443 billion ($18.7 million) and VND4.3 billion ($181,600), down 28% and 81%, respectively.
As of June 30, Mekophar's total assets were valued at VND1.54 trillion ($65.2 million), down 5% compared to the beginning of the year, with cash and cash equivalents at VND36.7 billion ($1.55 million), down 40%.
For 2023, the firm has targeted revenues and pre-tax profits of VND1.1 trillion ($46.5 million) and VND50 billion ($2.11 million), respectively.
On the Unlisted Public Company Market (UpCOM), MKP shares closed Tuesday’s session at VND26,600 ($1.12).
The firm attributed the loss to low demand and stiff competition, among other problems.
In stark contrast, Hau Giang Pharmaceutical JSC (DHG Pharma) reported an after-tax profit of VND263 billion ($11.1 million) in Q2, up 12% year-on-year.
The company, listed on the Ho Chi Minh Stock Exchange (HoSE) as DHG, posted a net revenue of nearly VND1.15 trillion ($48.7 million), up 3%, according to its financial statement.
Hau Giang Pharmaceutical said continued focus on trading strategic and key products, better organization of its distribution system as well as its connection with customers have helped its positive performance.
In the first six months of this year, DHG posted net revenues of VND2.38 trillion ($100.57 million) and after-tax profits of over VND624 billion ($26.4 million), up 9% and 27% year-on-year, respectively.
As of June 30, 2023, DHG's total assets value increased by 10.8% compared to the beginning of the year to VND5.73 trillion ($241.8 million). Of this, cash deposits of VND2.32 trillion ($98 million) and inventories worth VND1.49 trillion ($62.9 million) were down 1.5% and 19.1%, respectively.
For 2023, DHG Pharma has set revenue and pre-tax profit targets of VND5 trillion ($212.8 million) and VND1.13 trillion ($48.1 million), up 7% and 3% respectively.
At the close of Wednesday’s session, DHG was trading at VND124,400 ($5.25) per share.
Meanwhile, Imexpharm Corporation (IMP) posted net revenues and after-tax profits of nearly VND440 billion ($18.5 million) and VND79.7 billion ($3.4 million) in Q2, up 24% and 71% year-on-year, respectively.
Imexpharm recorded H1 net revenue and after-tax profits of VND919 billion ($38.8 million) and VND157.5 billion ($6.6 million), up 37% and 58%, respectively.
At the end of June, IMP's total assets stood at nearly VND2.52 trillion ($106.6 million), up 11% compared to the beginning of the year, with cash and cash equivalents at VND66.8 billion ($2.8 million), down 62%.
For 2023, IMP has set net revenue and pre-tax profit targets of VND1.62 trillion ($68.4 million) and VND305 billion ($12.88 million), respectively.
On the Ho Chi Minh Stock Exchange (HoSE), the IMP share price traded for VND72,500 ($3.06) at Wednesday's closing session.
Top broker SSI Securities said that while the post-pandemic situation will remain stable in most aspects, an economic downturn could stall spending on healthcare.
The first half of 2024 will be an unpredictable time for the supply of active pharmaceutical ingredients (API) and excipients. About 65% of API used in the production of drugs in Vietnam is imported from China, which has reopened, but SSI Securities predicted that shortages could still occur.
In addition, the Russia-Ukraine conflict continued and there was a risk of shortage of API and drugs imported from Europe. Companies that can use domestic raw materials will gain a better position, the broker said.
SSI expects pharma industry revenue to reach VND169 trillion ($7.2 billion) in 2023, up 8% year-on-year.
Meanwhile, Agribank Securities (Agriseco) assessed pharmaceutical industry profits would remain stable in 2023. The pharmaceutical industry is known to be a defensive one in the context of the economy facing many difficulties. Besides, Vietnam’s pharmaceutical industry still has a lot of potential for development in the medium and long term as the country’s population size is large and aging at a rapid rate. The increase in per capita income also helps people to spend more on medical and healthcare products, Agriseco noted.
- Read More
Vietnam PM calls for more investment from Qatar’s $475 bln sovereign wealth fund
Vietnamese Prime Minister Pham Minh Chinh has called on the Qatar Investment Authority (QIA), Qatar's sovereign wealth fund with total assets amounting to $475 billion as of 2023, to ramp up its investment in Vietnam.
Industries - Thu, October 31, 2024 | 4:43 pm GMT+7
FPT Retail earns $6.5 mln in Q3 profit, to expand FPT Shop chain
Vietnamese retail major FPT Retail made a profit after tax of VND165 billion ($6.52 million) in the third quarter of this year, while it incurred a loss of VND13 billion ($514,000) in the same period last year.
Companies - Thu, October 31, 2024 | 3:56 pm GMT+7
Germany’s PNE opens rep office for $4.6 bln offshore wind project in central Vietnam
Germany’s PNE AG, a leading developer of renewable energy projects, has shown its determination to proceed with a mega offshore wind power project in central Vietnam by opening a representative office there.
Energy - Thu, October 31, 2024 | 2:43 pm GMT+7
Saudi Arabian energy giant ACWA Power ready to invest $5 bln in Vietnam
Saudi Arabian private energy giant ACWA Power stands ready to invest up to $5 billion in Vietnam, a senior executive said Wednesday.
Industries - Thu, October 31, 2024 | 2:39 pm GMT+7
Effective M&A deal depends on thorough understanding, value addition potential: Kido exec
An effective M&A transaction depends on fully understanding the company being acquired in order to create added value, says Kido Group CEO Tran Le Nguyen.
Companies - Thu, October 31, 2024 | 1:22 pm GMT+7
No budget apartments in Vietnam, chronic supply-demand gap widens
Vietnam saw no supply or transaction of low-cost apartments priced below VND25 million ($988) per square meter in the third quarter, says a real estate report by the Ministry of Construction.
Real Estate - Thu, October 31, 2024 | 1:10 pm GMT+7
Vietnam steel major SMC remains bogged down with difficulties
Steel manufacturer SMC Trading Investment JSC has been actively selling assets to generate cash for debt repayment and maintain operations since the beginning of this year.
Companies - Thu, October 31, 2024 | 10:41 am GMT+7
Vinhomes’ earnings fall 39% to $777 mln in Jan-Sep
Vinhomes, the largest residential housing developer in Vietnam, booked a net profit of VND19,642 billion ($777 million) in the first three quarters this year, down 39.2% year-on-year.
Companies - Thu, October 31, 2024 | 9:58 am GMT+7
AI cannot replace customer service staff: MoMo exec
AI cannot replace customer service staff, but it can give them more time to prepare and provide better care for customers, says Thai Tri Hung, senior deputy general director and chief technology officer of e-wallet app MoMo.
Companies - Thu, October 31, 2024 | 8:11 am GMT+7
Vietnam property developer Novaland posts skyrocketing Q3 profit
Novaland, a leading real estate developer in Vietnam, reported its after-tax profit hit VND2.95 trillion ($166.62 million) in the third quarter of this year, a 21.6-fold rise year-on-year.
Companies - Wed, October 30, 2024 | 10:59 pm GMT+7
Thailand fruit prices increase at the end of successful season
Thailand’s fruit season is wrapping up this year with a notable surge in prices for durian, mangosteen, rambutan, longkong, and mango.
Southeast Asia - Wed, October 30, 2024 | 10:30 pm GMT+7
BlackBerry launches regional cybersecurity headquarters in Malaysia
Canada-based BlackBerry Ltd has established an Asia Pacific regional headquarters for its cybersecurity division in Cyberjaya, Malaysia, which is now fully operational.
Southeast Asia - Wed, October 30, 2024 | 10:27 pm GMT+7
Malaysia faces rising cybersecurity threats
Malaysian users are facing a high level of cyber threats, which may coincide with the rapid expansion of data centers in the country.
Southeast Asia - Wed, October 30, 2024 | 10:24 pm GMT+7
Indonesia to develop 3 million more hectares of rice fields
The Indonesian government is working to implement a program to develop 3 million hectares of new rice fields to strengthen the country's food resilience amid global challenges and increasing population demands, national news agency Antara reported.
Southeast Asia - Wed, October 30, 2024 | 9:24 pm GMT+7
Singapore’s digital economy thriving
Singapore’s digital economy accounted for 17.7% of the island state's GDP in 2023, up from 17.3% in the previous year, according to its Infocomm Media Development Authority (IMDA).
Southeast Asia - Wed, October 30, 2024 | 9:21 pm GMT+7
Viettel, UAE’s Presight to boost Applied AI, digital transformation in Vietnam
Vietnam’s Viettel AI and the UAE’s Presight have agreed to jointly advance the development of Applied AI and digital transformation initiatives in Vietnam.
Companies - Wed, October 30, 2024 | 8:30 pm GMT+7